Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 2
1997 2
1998 5
1999 5
2000 8
2001 13
2002 21
2003 10
2004 9
2005 17
2006 10
2007 9
2008 8
2009 9
2010 14
2011 28
2012 29
2013 29
2014 26
2015 25
2016 44
2017 42
2018 37
2019 39
2020 48
2021 16
Text availability
Article attribute
Article type
Publication date

Search Results

447 results
Results by year
Filters applied: . Clear all
Page 1
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, Hamann F, Heidbüchel H, Hindricks G, Kautzner J, Kuck KH, Mont L, Ng GA, Rekosz J, Schoen N, Schotten U, Suling A, Taggeselle J, Themistoclakis S, Vettorazzi E, Vardas P, Wegscheider K, Willems S, Crijns HJGM, Breithardt G; EAST-AFNET 4 Trial Investigators. Kirchhof P, et al. Among authors: eckardt l. N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29. N Engl J Med. 2020. PMID: 32865375 Clinical Trial.
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.
Vranckx P, Valgimigli M, Eckardt L, Tijssen J, Lewalter T, Gargiulo G, Batushkin V, Campo G, Lysak Z, Vakaliuk I, Milewski K, Laeis P, Reimitz PE, Smolnik R, Zierhut W, Goette A. Vranckx P, et al. Among authors: eckardt l. Lancet. 2019 Oct 12;394(10206):1335-1343. doi: 10.1016/S0140-6736(19)31872-0. Epub 2019 Sep 3. Lancet. 2019. PMID: 31492505 Clinical Trial.
[Typical atrial flutter: Diagnosis and therapy].
Thomas D, Eckardt L, Estner HL, Kuniss M, Meyer C, Neuberger HR, Sommer P, Steven D, Voss F, Bonnemeier H. Thomas D, et al. Among authors: eckardt l. Herzschrittmacherther Elektrophysiol. 2016 Mar;27(1):46-56. doi: 10.1007/s00399-016-0413-y. Epub 2016 Feb 4. Herzschrittmacherther Elektrophysiol. 2016. PMID: 26846223 Review. German.
Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials.
Gargiulo G, Goette A, Tijssen J, Eckardt L, Lewalter T, Vranckx P, Valgimigli M. Gargiulo G, et al. Among authors: eckardt l. Eur Heart J. 2019 Dec 7;40(46):3757-3767. doi: 10.1093/eurheartj/ehz732. Eur Heart J. 2019. PMID: 31651946
Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation.
Willems S, Meyer C, de Bono J, Brandes A, Eckardt L, Elvan A, van Gelder I, Goette A, Gulizia M, Haegeli L, Heidbuchel H, Haeusler KG, Kautzner J, Mont L, Ng GA, Szumowski L, Themistoclakis S, Wegscheider K, Kirchhof P. Willems S, et al. Among authors: eckardt l. Eur Heart J. 2019 Dec 7;40(46):3793-3799c. doi: 10.1093/eurheartj/ehz782. Eur Heart J. 2019. PMID: 31755940 Free PMC article. Review.
Marked and rapid effects of pharmacological HIF-2α antagonism on hypoxic ventilatory control.
Cheng X, Prange-Barczynska M, Fielding JW, Zhang M, Burrell AL, Lima JD, Eckardt L, Argles I, Pugh CW, Buckler KJ, Robbins PA, Hodson EJ, Bruick RK, Collinson LM, Rastinejad F, Bishop T, Ratcliffe PJ. Cheng X, et al. Among authors: eckardt l. J Clin Invest. 2020 May 1;130(5):2237-2251. doi: 10.1172/JCI133194. J Clin Invest. 2020. PMID: 31999648 Free PMC article.
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.
Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, S Lim H, Lip GYH, Nava-Townsend S, Pak HN, Rodríguez Diez G, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Molano LFP, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C. Nielsen JC, et al. Among authors: eckardt l. J Arrhythm. 2020 Jun 15;36(4):553-607. doi: 10.1002/joa3.12338. eCollection 2020 Aug. J Arrhythm. 2020. PMID: 32782627 Free PMC article. Review. No abstract available.
Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial.
Vranckx P, Lewalter T, Valgimigli M, Tijssen JG, Reimitz PE, Eckardt L, Lanz HJ, Zierhut W, Smolnik R, Goette A. Vranckx P, et al. Among authors: eckardt l. Am Heart J. 2018 Feb;196:105-112. doi: 10.1016/j.ahj.2017.10.009. Epub 2017 Oct 23. Am Heart J. 2018. PMID: 29421002 Free article. Clinical Trial.
Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.
Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil P, Scholten M, Hood M, Kuschyk J, Jones P, Duffy E, Husby M, Stein K, Lambiase PD; EFFORTLESS Investigator Group. Boersma L, et al. Among authors: eckardt l. J Am Coll Cardiol. 2017 Aug 15;70(7):830-841. doi: 10.1016/j.jacc.2017.06.040. J Am Coll Cardiol. 2017. PMID: 28797351 Free article.
447 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page